iSD Immunotech ApS
CVR number: 30738276
Stærmosevej 12 A, 7120 Vejle Øst
ch@isd-immunotech.com
tel: 60734254
www.isd-immunotech.com
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 388.79 | 3 067.30 | 167.66 | 564.96 | 2 289.20 |
| Employee benefit expenses | - 241.40 | - 318.69 | -1 285.55 | -1 970.77 | -1 793.23 |
| Total depreciation | -14 918.98 | ||||
| EBIT | - 630.19 | 2 748.61 | -1 117.90 | -1 405.82 | -14 423.01 |
| Other financial income | 0.07 | 25.70 | 0.24 | 8.21 | 25.81 |
| Other financial expenses | -94.98 | - 211.22 | - 205.34 | - 263.61 | - 201.36 |
| Pre-tax profit | - 725.10 | 2 563.08 | -1 323.00 | -1 661.22 | -14 598.56 |
| Income taxes | 136.08 | - 343.00 | 562.86 | 604.22 | 1 299.00 |
| Net earnings | - 589.02 | 2 220.08 | - 760.13 | -1 057.00 | -13 299.56 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 1 583.53 | 3 604.99 | 8 811.83 | 12 972.03 | 250.00 |
| Intangible assets total | 1 583.53 | 3 604.99 | 8 811.83 | 12 972.03 | 250.00 |
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Prepayments and accrued income | 8.53 | 29.93 | 7.68 | 3.74 | |
| Current other receivables | 63.68 | 186.62 | 915.63 | 33.21 | 40.66 |
| Current deferred tax assets | 45.72 | 908.87 | 820.22 | 394.00 | |
| Short term receivables total | 109.40 | 195.16 | 1 854.42 | 861.11 | 438.40 |
| Cash and bank deposits | 187.27 | 5 292.68 | 8 880.07 | 5 519.06 | 1 040.06 |
| Cash and cash equivalents | 187.27 | 5 292.68 | 8 880.07 | 5 519.06 | 1 040.06 |
| Balance sheet total (assets) | 1 880.21 | 9 092.82 | 19 546.32 | 19 352.19 | 1 728.46 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 142.22 | 186.99 | 224.98 | 224.98 | 224.98 |
| Other reserves | 1 235.16 | 2 811.89 | 6 873.23 | 10 118.19 | |
| Retained earnings | -1 048.19 | 1 756.20 | 7 700.66 | 3 695.57 | 12 756.75 |
| Profit of the financial year | - 589.02 | 2 220.08 | - 760.13 | -1 057.00 | -13 299.56 |
| Shareholders equity total | - 259.84 | 6 975.16 | 14 038.73 | 12 981.73 | - 317.83 |
| Provisions | 343.00 | 689.00 | 905.00 | ||
| Capital loans | 1 000.00 | 1 060.00 | 873.60 | 1 191.02 | 1 262.48 |
| Non-current loans from credit institutions | 1 070.00 | 1 550.14 | 1 635.19 | ||
| Non-current liabilities total | 2 070.00 | 1 060.00 | 2 423.74 | 2 826.21 | 1 262.48 |
| Current loans from credit institutions | 777.92 | 580.12 | 626.53 | ||
| Current trade creditors | 68.93 | 521.50 | 230.45 | 354.24 | 70.30 |
| Other non-interest bearing current liabilities | 1.12 | 193.16 | 90.13 | 86.89 | 86.98 |
| Accruals and deferred income | 1 296.36 | 1 618.01 | |||
| Current liabilities total | 70.05 | 714.67 | 2 394.85 | 2 639.26 | 783.81 |
| Balance sheet total (liabilities) | 1 880.21 | 9 092.82 | 19 546.32 | 19 352.19 | 1 728.46 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.